ClinicalTrials.Veeva

Menu

Mobile Attentional Bias Modification Training in Pediatric MS

NYU Langone Health logo

NYU Langone Health

Status

Completed

Conditions

Pediatric Multiple Sclerosis

Treatments

Behavioral: ABMT mobile application

Study type

Interventional

Funder types

Other

Identifiers

NCT04441229
19-00810

Details and patient eligibility

About

This study will examine the feasibility of using a mobile ABMT application as a treatment modality in the Pediatric Multiple Sclerosis population. Participants will be asked to undergo one hour-long baseline evaluation, followed by at-home ABMT application sessions. Subjects will complete online REDCap or MyCap surveys weekly and at the end of the study.

Enrollment

37 patients

Sex

All

Ages

12 to 24 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 12-24 years
  • Confirmed Diagnosis of Multiple Sclerosis with onset < 17 years and 11 months (defined by the 2013 International Pediatric MS Study Group (IPMSSG) criteria (Krupp, Tardieu, Amato, Banwell, Chitnis, Dale, Ghezzi, Hintzen, Kornberg, Pohl, Rostasy, Tenembaum, Wassmer, & Sclerosis, 2013) and the 2010 McDonald criteria (Polman et al., 2011).)
  • Followed at NYU Multiple Sclerosis Comprehensive Care Center
  • Access to a mobile device with iOS (devices will be provided to subjects if this criteria is not met, see section 4.4)
  • Active or concurrently enrolled in the ongoing US Network of Pediatric MS Centers Study Consortium

Exclusion criteria

  • Previous report of an IQ < 70
  • Wide-Range Achievement Test-Fourth Edition (Wilkerson, 2006) Reading Subtest standard score <85
  • Non-English speaking, learned English in the past three years, or learned English after the age of 12 years
  • Not willing to comply with all study procedures
  • Insufficient visual and motor ability to operate the intervention and assessments

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

37 participants in 1 patient group

Treatment Group
Experimental group
Description:
Patients age 12-24 diagnosed with pediatric-onset Multiple Sclerosis
Treatment:
Behavioral: ABMT mobile application

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems